BioMarin: Genzyme virus problem won

moffaiqohegesa1490.blogspot.com
Genzyme (NASDAQ: GENZ) found a virus strainn and stopped production of two drugs atthe Allston, facility. The strain, Vesivirus apparently does not cause humanb infection but interrupts the growtyh of cells that are used tomake drugs. Aldurazyme — a treatment for MPS I, a rare and fatalo disease caused by an enzymedeficiency — was last fillexd at the Genzyme facility in Septembedr 2008, according to BioMarin BMRN). The company has about 10 monthes of vialed inventory on it said, and uses a second fill finishh supplier. A third supplier is expected to be qualifiec laterthis year, BioMarin said. BioMarijn makes the bulk material used in Aldurazyme at itsNovatol facility.
The Food and Drug Administration hadinspectes Genzyme’s plant in Septembet and October and reportedly was concerned about controls to protecrt against contamination.